DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo


company name or ticker

Sector Update: Healthcare

Cyclacel Reports Positive Phase 2 Data of Sapacitabine for MDS at ASH

Cyclacel Rising

Cyclacel Pharma Announces Data Safety Monitoring Board Recommends Continuation of SEAMLESS Study of

Cyclacel Pharma Announces Data Safety Monitoring Board Recommends Continuation of SEAMLESS Study of Sapacitabine in AML

Cyclacel Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript

Cyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock Ex-Dividend Reminder - 10/17/13

Cyclacel Pharmaceuticals Preferred Shares: An Investigative Report

First Week Of November 16th Options Trading For Cyclacel Pharmaceuticals (CYCC)

Morning Market Losers

Healthcare Stocks Sliding Near Close; Cyclacel Pharma Spikes After Anti-Tumor Drug Shows Added Promi

Healthcare Stocks Sliding Near Close; Cyclacel Pharma Spikes After Anti-Tumor Drug Shows Added Promise
See More Articles...